Aclaris Therapeutics's total assets for Q3 2025 were $175.53M, a decrease of -7.20% from the previous quarter. ACRS total liabilities were $55.43M for the fiscal quarter, a -3.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.